Invasive Fungal Infections Recruiting Phase 3 Trials for Sulfamethoxazole (DB01015)

Back to Invasive Fungal Infections

Also known as: Invasive Fungal Infection / Invasive Mycosis / Invasive Infection, Fungal / Infection, Invasive Fungal / Invasive Fungal Disease / Fungal Invasive Disease / Invasive fungal infection (disorder) / Systemic fungal infection NOS / Disseminated mycosis / Systemic mycosis / Systemic mycosis (disorder)

Indication	Status	Phase
DBCOND0030131 (Invasive Fungal Infections)	Recruiting	3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04368559	Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation	Prevention	Fluconazole (DB00196) Microcrystalline cellulose (DB14158) Posaconazole (DB01263) Rezafungin (DB16310) Sulfamethoxazole (DB01015) Trimethoprim (DB00440)